Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the beginning of 2018. Several of the CTS client forms specify list the Medical Director in the header and these forms will be updated on March 5, 2018. Check out the Communication page for a complete list of forms or by clicking the link below: Communications
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...